197 related articles for article (PubMed ID: 35049225)
21. Downregulation of microRNA-376a in Gastric Cancer and Association with Poor Prognosis.
Zhang C; Liang Y; Ma MH; Wu KZ; Zhang CD; Dai DQ
Cell Physiol Biochem; 2018; 51(5):2010-2018. PubMed ID: 30522118
[TBL] [Abstract][Full Text] [Related]
22. Upregulated expression of long noncoding RNA SNHG15 promotes cell proliferation and invasion through regulates MMP2/MMP9 in patients with GC.
Chen SX; Yin JF; Lin BC; Su HF; Zheng Z; Xie CY; Fei ZH
Tumour Biol; 2016 May; 37(5):6801-12. PubMed ID: 26662309
[TBL] [Abstract][Full Text] [Related]
23. Analysis of Collagen type X alpha 1 (COL10A1) expression and prognostic significance in gastric cancer based on bioinformatics.
Chen S; Wei Y; Liu H; Gong Y; Zhou Y; Yang H; Tang L
Bioengineered; 2021 Dec; 12(1):127-137. PubMed ID: 33371777
[TBL] [Abstract][Full Text] [Related]
24. GPRC5A overexpression predicted advanced biological behaviors and poor prognosis in patients with gastric cancer.
Liu H; Zhang Y; Hao X; Kong F; Li X; Yu J; Jia Y
Tumour Biol; 2016 Jan; 37(1):503-10. PubMed ID: 26227221
[TBL] [Abstract][Full Text] [Related]
25. Upregulated expression of SAC3D1 is associated with progression in gastric cancer.
Liu AG; Zhong JC; Chen G; He RQ; He YQ; Ma J; Yang LH; Wu XJ; Huang JT; Li JJ; Mo WJ; Qin XG
Int J Oncol; 2020 Jul; 57(1):122-138. PubMed ID: 32319600
[TBL] [Abstract][Full Text] [Related]
26. Bioinformatic exploration of OLFML2B overexpression in gastric cancer base on multiple analyzing tools.
Liu J; Liu Z; Zhang X; Gong T; Yao D
BMC Cancer; 2019 Mar; 19(1):227. PubMed ID: 30866865
[TBL] [Abstract][Full Text] [Related]
27. NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer.
Yu ZH; Wang YM; Jiang YZ; Ma SJ; Zhong Q; Wan YY; Wang XW
Pathol Res Pract; 2019 Oct; 215(10):152553. PubMed ID: 31362888
[TBL] [Abstract][Full Text] [Related]
28. FLAD1 is up-regulated in Gastric Cancer and is a potential prediction of prognosis.
Hu P; Pan Y; Wang C; Zhang W; Huang H; Wang J; Zhang N
Int J Med Sci; 2020; 17(12):1763-1772. PubMed ID: 32714079
[No Abstract] [Full Text] [Related]
29. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT.
Hu Q; Masuda T; Kuramitsu S; Tobo T; Sato K; Kidogami S; Nambara S; Ueda M; Tsuruda Y; Kuroda Y; Ito S; Oki E; Mori M; Mimori K
PLoS One; 2020; 15(10):e0241140. PubMed ID: 33095806
[TBL] [Abstract][Full Text] [Related]
30. MiR-511-5p functions as a tumor suppressor and a predictive of prognosis in colorectal cancer by directly targeting GPR116.
Wang C; Fan HQ; Zhang YW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6119-6130. PubMed ID: 31364112
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA hsa-mir-3923 serves as a diagnostic and prognostic biomarker for gastric carcinoma.
Yang X; Zhang Z; Zhang L; Zhou L
Sci Rep; 2020 Mar; 10(1):4672. PubMed ID: 32170105
[TBL] [Abstract][Full Text] [Related]
32. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients.
Li G; Xu J; Wang Z; Yuan Y; Li Y; Cai S; He Y
J Cancer Res Clin Oncol; 2015 Mar; 141(3):443-52. PubMed ID: 25261987
[TBL] [Abstract][Full Text] [Related]
33. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma.
Chen H; Ren C; Han C; Wang D; Chen Y; Fu D
PLoS One; 2015; 10(3):e0119384. PubMed ID: 25793394
[TBL] [Abstract][Full Text] [Related]
34. High expression of MRE11 correlates with poor prognosis in gastric carcinoma.
Li J; Su T; Yang L; Zhang C; He Y
Diagn Pathol; 2019 Jun; 14(1):60. PubMed ID: 31221177
[TBL] [Abstract][Full Text] [Related]
35. Thrombospondin-2 holds prognostic value and is associated with metastasis and the mismatch repair process in gastric cancer.
Chu XD; Lin ZB; Huang T; Ding H; Zhang YR; Zhao Z; Huangfu SC; Qiu SH; Guo YG; Chu XL; Pan JH; Pan YL
BMC Cancer; 2022 Mar; 22(1):250. PubMed ID: 35255858
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Transcription Factor 7 (TCF7) as a Prognostic Factor in Gastric Cancer.
Xu X; Liu Z; Tian F; Xu J; Chen Y
Med Sci Monit; 2019 May; 25():3957-3963. PubMed ID: 31133633
[TBL] [Abstract][Full Text] [Related]
37. COL5A2 is a prognostic-related biomarker and correlated with immune infiltrates in gastric cancer based on transcriptomics and single-cell RNA sequencing.
Chen M; Zhu X; Zhang L; Zhao D
BMC Med Genomics; 2023 Sep; 16(1):220. PubMed ID: 37723519
[TBL] [Abstract][Full Text] [Related]
38. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of SMYD3 and matrix metalloproteinase-9 are associated with poor prognosis of patients with gastric cancer.
Liu Y; Liu H; Luo X; Deng J; Pan Y; Liang H
Tumour Biol; 2015 Jun; 36(6):4377-86. PubMed ID: 25627005
[TBL] [Abstract][Full Text] [Related]
40. Increased lncRNA AFAP1-AS1 expression predicts poor prognosis and promotes malignant phenotypes in gastric cancer.
Feng Y; Zhang Q; Wang J; Liu P
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3842-3849. PubMed ID: 28975981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]